{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:03:39Z","timestamp":1789621419115,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Valproate poisoning is a potentially life-threatening condition that may result in central nervous system depression, hyperammonemia, metabolic disturbances, and multiorgan dysfunction. Management of massive sustained-release valproate overdose remains challenging because delayed gastrointestinal absorption may lead to prolonged toxicity despite conventional decontamination measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>A 23-year-old woman with a history of previous suicide attempts was admitted approximately 6\u00a0hours after ingesting ninety 500-mg sustained-release valproate tablets (total dose 45\u00a0g) with alcohol. Upon arrival, she exhibited severe agitation and delirium. Endotracheal intubation was performed for airway protection because she was unable to cooperate with treatment and was at risk of aspiration. Gastric lavage and cathartic therapy were subsequently administered. The initial serum valproate concentration was 1,093.66\u00a0\u03bcg\/mL. Because incomplete decontamination was suspected, bedside upper gastrointestinal endoscopy was performed approximately 11.5\u00a0h after ingestion. Fourteen intact and markedly swollen tablets were removed; some were separate, whereas others were adherent and partially aggregated, supporting partial pharmacobezoar formation and prolonged gastric drug retention. During intensive care unit management, the patient developed severe hyperammonemia (peak ammonia 205\u00a0\u03bcmol\/L), hyperlactatemia with mixed metabolic acidosis and respiratory alkalosis, acute kidney injury, marked creatine kinase elevation, hypernatremia, and suspected transient central diabetes insipidus. Meropenem was administered empirically from May 31 to June 3 because impaired airway defenses after intubation raised concern for aspiration-related infection, although no definite infectious focus or causative pathogen was identified. Because of substantial financial hardship, extracorporeal treatment was initially deferred. It was initiated at 20:00 on June 1, approximately 62\u00a0h after ingestion and 56\u00a0h after hospital admission. Two consecutive 2-h sessions of hemoperfusion combined with CVVH were followed by CVVH alone until 08:30 on June 2. The serum valproate concentration decreased from 397.05\u00a0\u03bcg\/mL before extracorporeal treatment to 12.72\u00a0\u03bcg\/mL during ongoing CVVH and was 8.61\u00a0\u03bcg\/mL approximately 70\u00a0h after treatment cessation. The patient was discharged on June 15 without evident neurological, cognitive, or motor impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Massive sustained-release valproate overdose may cause prolonged gastric retention of intact and partially aggregated tablets, thereby sustaining systemic toxicity. In selected patients, endoscopic tablet removal may provide toxicological source control, while extracorporeal treatment may remain beneficial even when its initiation is delayed. The respective contributions of endoscopy, meropenem exposure, spontaneous elimination, and extracorporeal treatment cannot be separated in this single case.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1923807","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:29:16Z","timestamp":1789619356000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Massive sustained-release valproate overdose with prolonged gastric tablet retention and partial pharmacobezoar formation managed by endoscopic removal and delayed extracorporeal therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Pochen","family":"Li","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Ge","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Li","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Yu","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e96884","DOI":"10.7759\/cureus.96884","article-title":"Massive valproic acid overdose with confirmed pharmacobezoar formation and neuromuscular toxicity: a case report and literature review","volume":"17","author":"Alrazooqi","year":"2025","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1080\/15563650.2026.2663138","article-title":"Bupropion overdose: insights on the role of upper gastrointestinal decontamination endoscopy","volume":"64","author":"Bernasconi","year":"2026","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/bdd.2510060406","article-title":"Pharmacokinetic evaluation of novel sustained-release dosage forms of valproic acid in humans","volume":"6","author":"Bialer","year":"1985","journal-title":"Biopharm. Drug Dispos."},{"key":"B4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/15563650.2025.2508428","article-title":"Characterizing pharmacobezoar formation: a descriptive analysis from VigiBase","volume":"63","author":"Carollo","year":"2025","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2015.1035441","article-title":"Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"53","author":"Ghannoum","year":"2015","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/bcp.16379","article-title":"Gut decontamination in the poisoned patient","volume":"91","author":"Gosselin","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bcp.16233","article-title":"L-carnitine for valproic acid-induced toxicity","volume":"91","author":"Gziut","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B8","first-page":"335","article-title":"Interaction between valproic acid and meropenem or ertapenem in patients with epilepsy: clinical relevance and results from pharmaceutical intervention","volume":"45","author":"Hern\u00e1ndez-Ramos","year":"2021","journal-title":"Farm Hosp."},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pharep.2016.12.003","article-title":"Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning","volume":"69","author":"Jawie\u0144","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/bcp.16376","article-title":"Carbapenems in the management of valproic acid overdose","volume":"91","author":"Juurlink","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e8367","DOI":"10.1002\/ccr3.8367","article-title":"Rescue strategies for valproic acid overdose poisoning: case series and literature review","volume":"12","author":"Liu","year":"2023","journal-title":"Clin. Case Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.farma.2025.06.013","article-title":"In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets","volume":"50","author":"L\u00f3pez","year":"2026","journal-title":"Farm Hosp."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2019-0028","article-title":"Meropenem for management of valproic acid overdose: a case report","volume":"35","author":"Mu\u00f1oz-Pichuante","year":"2020","journal-title":"Drug Metab. Pers. Ther."},{"key":"B14","article-title":"Valproate toxicity","volume-title":"Statpearls","author":"Patel","year":"2024"},{"key":"B15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.36290\/vnl.2019.076","article-title":"Mimot\u011bln\u00ed elimina\u010dn\u00ed metody v toxikologii: 2. \u010d\u00e1st [Extracorporeal removal techniques in toxicology: part 2]","volume":"65","author":"Rad\u011bj","year":"2019","journal-title":"Vnitr Lek."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/jat.70095","article-title":"L-Carnitine and Acetyl-L-Carnitine in drug poisonings: a systematic review of clinical and experimental evidence","volume":"46","author":"Rezaee","year":"2026","journal-title":"J. Appl. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20451253251385730","DOI":"10.1177\/20451253251385730","article-title":"Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysis","volume":"15","author":"Riboldi","year":"2025","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3109\/00498254.2011.596582","article-title":"Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid","volume":"41","author":"Suzuki","year":"2011","journal-title":"Xenobiotica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1081\/clt-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"690.e1","DOI":"10.1016\/j.ajem.2019.09.011","article-title":"Meropenem as an antidote for intentional valproic acid overdose","volume":"38","author":"Thomas","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0378-5173(01)00916-4","article-title":"Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers","volume":"233","author":"Torii","year":"2002","journal-title":"Int. J. Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5847\/wjem.j.1920-8642.2025.025","article-title":"Pharmacobezoars: the challenges of gastric lavage for a patient with drug overdose","volume":"16","author":"Wang","year":"2025","journal-title":"World J. Emerg. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40262-025-01559-4","article-title":"Double peaking phenomena in pharmacokinetic disposition revisited","volume":"64","author":"Yousef","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1423411","DOI":"10.3389\/fphar.2024.1423411","article-title":"Combined carbapenem resulted in a 4.48-fold increase in valproic acid clearance: a population pharmacokinetic model in Chinese children and adults with epilepsy or after neurosurgery","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1923807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:29:23Z","timestamp":1789619363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1923807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":24,"alternative-id":["10.3389\/fphar.2026.1923807"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1923807","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1923807"}}